CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $16,000 | -87.7% | 461 | -91.7% | 0.00% | – |
Q1 2021 | $130,000 | +78.1% | 5,527 | +120.4% | 0.00% | – |
Q4 2020 | $73,000 | +180.8% | 2,508 | +91.2% | 0.00% | – |
Q3 2020 | $26,000 | -63.9% | 1,312 | -44.6% | 0.00% | – |
Q2 2020 | $72,000 | +30.9% | 2,369 | +35.8% | 0.00% | – |
Q1 2020 | $55,000 | 0.0% | 1,744 | +48.4% | 0.00% | – |
Q4 2019 | $55,000 | +48.6% | 1,175 | -79.6% | 0.00% | – |
Q3 2019 | $37,000 | – | 5,750 | +31844.4% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 18 | -92.7% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 246 | +112.1% | 0.00% | – |
Q3 2018 | $1,000 | – | 116 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |